Market Size – USD 7.2 Billion in 2019, Market Growth – CAGR of 9.1%, Market Trends– Advancements in In-Vitro Toxicology/Toxicity Testing platform and improved regulations for animal protection.
According to the current analysis of Reports and Data, the global In-Vitro Toxicology/Toxicity Testing market was valued at USD 7.2 billion in 2019 and is expected to reach USD 14.6 billion by 2027, at a CAGR of 9.1 %. The opposition to animal testing, innovative advancements, and expanding R&D consumption to distinguish toxicity at the beginning phase during drug improvement are the essential development factors for this industry. The expanding focus of the pharmaceutical and cosmetics products enterprises on utilizing in-vitro strategies for product testing alongside the growth in silico techniques for prescient toxicology contemplates are required to offer enormous opportunities for players in this market.
The widening horizon of high-throughput screening (HTS) strategies has urged drug makers to embrace these practical and time-effective procedures for toxicological assessment. For example, in October 2019, the HTS information from the ToxCast program, started by the U.S. EPA to assess the toxic capability of synthetic compounds, was used for the risk evaluation of food contact materials an assessment system called RISK 21.
Get a Sample of the Report @ https://www.reportsanddata.com/sample-enquiry-form/3377
The benefits of this division over conventional techniques incorporate rapid assessment of the safety of the innovative item, cost-sparing, and even efficiency, which are foreseen to drive the market. Moreover, the market’s opportunity to develop includes a developing focus on drug discovery and personalized medication by methods for In-Vitro Methods. Also, the absence of In-Vitro models to contemplate complex endpoints and the inability to teach in-vivo conditions for the different cell cultures to become are susceptible to hinder the development of the market soon.
The COVID-19 impact:
The outbreak raised concern for the patient dealing with other underlying conditions. However, government authorities had laid down several guidelines to ensure patient safety and healthcare professional safety. The market has experienced a downturn over the weeks, which may continue over the next few months. The increased patient pool suffering from COVID-19 has disrupted the balance in healthcare. This pandemic has affected the Asia Pacific region the most, with China at the center of the outbreak. Most initiatives have come to a temporary halt in multiple countries changed. The production of In-Vitro Toxicology/Toxicity Testing and supply chain has been put on hold, causing losses to the manufacturers, dealers, and consumers. The market might be facing a downside for the period. With a rising health concern, the demand would be hitting the roof as soon as there is a development in the condition.
The global In-Vitro Toxicology/Toxicity Testing market:
- Bio-Rad Laboratories
- GE Healthcare
- Thermo Fisher Scientific
- Eurofins Scientific SE
- Merck KGaA
- Charles River Laboratories International
- QIAGEN N.V.
- Promega Corporation
- Gentronix Limited.
For the purpose of this report, Reports and Data have segmented into the global In-Vitro Toxicology/Toxicity Testing market on the basis of products & services, technologies, methods, end point, end-use, and region:
Products and Services Outlook (Revenue in USD Billion; 2017–2027)
- Bacterial Toxicity Assays
- Enzyme Toxicity Assays
- Cell Based Elisa and Western Blots
- Tissue Culture Assays
- Receptor Binding Assays
- Other Assays
- Reagents and Labwares
Technology Outlook (Revenue in USD Billion; 2017–2027)
- Cell Culture
Methods Outlook (Revenue in USD Billion; 2017–2027)
- Cellular Assays
- Biochemical Assays
End Point Outlook (Revenue in USD Billion; 2017–2027)
- Occular Toxicity
- Organ Toxicity
- Photo Toxicity
- Dermal Toxicity
- Skin Irritation, Corrosion, Sensitization
End-Use Outlook (Revenue in USD Billion; 2017–2027)
- Pharmaceutical Industry
- Chemicals Industry
- Cosmetics and Household Products
- Food Industry
Regional Outlook (Revenue, USD Billion; 2017-2027)
- North America
- Rest of the Europe
- Asia Pacific
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Latin America
Further key findings from the report suggest
- North America held the largest market share of 35.9% in the year 2019. High government activities for mindfulness in the insurance of the animals are boosting the development of the market.
- Organ Toxicity held the most significant piece of the overall industry in the year 2019. The portion is additionally expected to develop at the pace of 8.9%, owing to it to the developing concentration upon drug safety.
- Dermal Toxicity by End-Point section held a piece of the overall industry of 22.1% in the year 2019. The segment is expected to develop at the most prominent rate because of the increasing requirement for cosmetic industry advancements.
- The expanding interest in cost-sparing toxicology testing and rising research and development will fuel the market development in APAC.
- About 47.6% of the global In-Vitro Toxicology market is occupied by Cell Culture segment.
- In May 2019, Avon, a cosmetics organization, has expressed its help for a worldwide restriction on animal testing of makeup, as a component of the coordinated effort with animal protection NGO, Humane Society International. The rising joint efforts to prevent animal testing in the makeup business are foreseen to drive the market for the upcoming forecast period.
Table Of content:
Chapter 1. Market Synopsis
1.1. Market Definition
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2017-2027
Chapter 3. Indicative Metrics
3.1. Macro-Economic Indicators
3.1.1. Rising technological advancements
Chapter 4. COVID 19 impact assessment
4.1. In-Vitro Toxicology/Toxicity Testing market industry outlook (2020)
Chapter 13. Company Profiles
13.1.1. Company Overview
13.1.2. Financial Insights
13.1.3. Products and Services Offered
13.1.4. Strategic Initiatives
13.2. Bio-Rad Laboratories, Inc.
13.2.1. Company Overview
13.2.2. Financial Insights
13.2.3. Products and Services Offered
13.2.4. Strategic Initiatives
13.3. GE Healthcare
13.3.1. Company Overview
13.3.2. Financial Insights
13.3.3. Products and Services Offered
13.3.4. Strategic Initiatives
13.4. Thermo Fisher Scientific Inc.
13.4.1. Company Overview
13.4.2. Financial Insights
13.4.3. Products and Services Offered
13.4.4. Strategic Initiatives
13.5. Eurofins Scientific SE
13.5.1. Company Overview
13.5.2. Financial Insights
13.5.3. Products and Services Offered
13.5.4. Strategic Initiatives
13.6. Merck KGaA
13.6.1. Company Overview
13.6.2. Financial Insights
Request for Customization of Report @ https://www.reportsanddata.com/request-customization-form/3377
Thank you for reading our report. Customization of the report is available according to the requirements of the clients. Kindly get in touch with us to know more about the report, and our team will ensure the report is tailored according to your needs.
About Reports and Data:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.
Company Name: Reports and Data
Contact Person: John Watson
Email: Send Email
Address:40 Wall St. 28th floor
City: New York City
State: NY 10005
Country: United States